Transmedics
TMDX
248 hedge funds and large institutions have $2.76B invested in Transmedics in 2023 Q4 according to their latest regulatory filings, with 49 funds opening new positions, 78 increasing their positions, 91 reducing their positions, and 21 closing their positions.
133% more first-time investments, than exits
New positions opened: 49 | Existing positions closed: 21
120% more funds holding in top 10
Funds holding in top 10: 5 → 11 (+6)
56% more call options, than puts
Call options by funds: $15.5M | Put options by funds: $9.94M
44% more capital invested
Capital invested by funds: $1.91B → $2.76B (+$847M)
12% more funds holding
Funds holding: 221 → 248 (+27)
0.08% more ownership
Funds ownership: 107.08% → 107.16% (+0.08%)
14% less repeat investments, than reductions
Existing positions increased: 78 | Existing positions reduced: 91
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Mackenzie Financial
Toronto Ontario,
Ontario, Canada
|
+$27.4M |
| 2 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$21.3M |
| 3 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$16.8M |
| 4 |
RA
Royce & Associates
New York
|
+$12.7M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$9.28M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Allspring Global Investments
Charlotte,
North Carolina
|
-$34M |
| 2 |
NIP
Nicholas Investment Partners
Rancho Santa Fe,
California
|
-$21.4M |
| 3 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$16.4M |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$14.2M |
| 5 |
FAM
Fred Alger Management
New York
|
-$14M |
TMDX Hedge Fund Activity: Q4 2023 in Review
248 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in Transmedics (TMDX) for Q4 2023, worth a combined $2.76B — up 44% from $1.91B a quarter earlier.
Buyers outnumbered sellers: 49 funds opened new TMDX positions and 21 closed out — a net gain of 28 holders — while 78 added to existing stakes and 91 trimmed.
The largest buyer was Mackenzie Financial, opening a new position worth an estimated $27.4M. The largest seller was Allspring Global Investments, cutting an estimated $34M.
- 248 institutional investors held Transmedics (TMDX) as of Q4 2023, up from 221 in Q3 2023.
- Funds reported $2.76B of Transmedics stock for Q4 2023, up 44% quarter-over-quarter.
- 49 funds opened new Transmedics positions in Q4 2023 and 21 closed out, a net change of +28 holders.
- The largest Transmedics buyer in Q4 2023 was Mackenzie Financial, an estimated $27.4M added.
- The largest Transmedics seller in Q4 2023 was Allspring Global Investments, an estimated $34M sold.
Based on aggregated 13F filings for Q4 2023.